Genitourinary and Reproductive Flashcards
Why is progesterone included with estrogen for treating menopause?
It protects from increased risk of endometrial cancer
(estrogen only is fine if prior hysterectomy)
Estrogen hormone replacement therapy
Prototype
conjugated equine estrogen (Premarin)
transdermal Estradiol (FemPatch, Estraderm, Climara)
estradiol cream (Estrace)
estradiol intravaginal tabs (Vagifem)
Estrogen hormone replacement therapy
MOA
Binds to estrogen receptors in breasts, genitals, hypothalamus and pituitary gland
Provides small, stable amount of estrogen to prevent menopause symptoms
Estrogen hormone replacement therapy
Adverse Effects
Nausea
HTN (increased angiotensin and aldosterone)
Water retention
Endometrial hyperplasia (increased risk of endometrial and ovarian cancers)
Thromboembolic events
Estrogen hormone replacement therapy
Teaching
- Quit smoking
- Monitor for pain, redness, and swelling in leg, dypsnea, chest pain
- Stop 4 weeks before surgery due to thromboembolic event risk
- Monitor vaginal bleeding (may indicate cancer)
- Nausea goes away with time
Estrogen hormone replacement therapy
Admin
Continuous use and at same time daily to avoid bleeding
Cream or intravag tabs at bedtime
Estrogen hormone replacement therapy
Contraindications
- hx of thromboembolic events
- Breast, ovarian, endometrial, or vaginal cancer
- Undiagnosed vag bleeding
- Liver disease
Estrogen hormone replacement therapy
Common interactions
Decreased effect with St. John’s Wort, anticonvulsants, some antibiotics
Reduces effectiveness of warfarin and diabetes meds
Increase levels of diazepam, chlordiazepoxide, TCAs, and theophylline
Estrogen and progesterone hormone replacement therapy
Indication
Severe menopause symptoms: hot flashes and vaginal atrophy
Prevents menopausal osteoporosis
Estrogen and progesterone hormone replacement therapy
Prototype
conjugated estrogen and medroxyprogestrone acetate (Prempro)
transdermal estradiol and norethindrone (CombiPatch)
Estrogen and progesterone hormone replacement therapy
MOA
Estrogen binds to target tissues to prevent menopause symptoms.
Progesterone antagonizes tissue growth in endometrium caused by estrogen
Estrogen and progesterone hormone replacement therapy
Adverse effects
Even greater risk of thromboembolic event
Increased risk for vaginal bleeding, weight gain, breast cancer
GrH agonist
Prototype
Leuprolide (Lupron)
Nafarelin (Synarel)
GrH agonist
classification
Gonadotropin releasing hormone antineoplastic
GrH agonists
MOA
Stimualates secretion of FSH and LH from pituitary gland, which increases estrogen and progesterone.
After several weeks, FSH and LH drop drastically to the point of monopausal hormone levels
This allows endometrium to shrink
GrH agonists
Indication
Endometrial hyperplasia
Endometriosis
GrH agonists
Adverse effects
Hot flashes
Headache
Vaginal dryness
Bone loss
GnRH agonists
Interventions
- Therapy limited to 6 mo to prevent osteoporosis
- Bone density scanning if must last longer
GnRH agonists
Admin
Intramuscular injection
GnRH agonists
Instructions
- Perform weight bearing exercises daily and take calcium and vit D
- Lube for vaginal dryness
GnRH agonists
Contraindications
Pregnancy
Abnormal vag bleeding
Metastatic brain cancer
Allergy to benzoyl alcohol
Progesterone
Prototype
medroxyprogesterone acetate (Provera)
norethindrone (Micronor)
Progesterone
Indication
Endometriosis
Abnormal bleeding
Palliative tx for advanced uterine cancer
Progesterone
MOA
Antagonizes estrogen from causing endometrial growth
LH and FSH stimulants
Prototype
clomiphene (Clomid)